Function and Scoliosis Surgery
Functional Testing, and Biomechanics Before and After Scoliosis Surgery
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of idiopathic scoliosis
- Patients identified to undergo spinal fusion surgery
- Treated at Duke University Medical Center
Exclusion Criteria:
- Neuromuscular or congenital scoliosis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Lower Quarter Y-Balance Test (YBT-LQ)
Time Frame: Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
The YBT-LQ is a test of dynamic balance in unilateral stance that has been deemed to be reliable and valid.
The YBT-LQ consists of each patient standing on one leg and reaching as far as they can with their non-stance leg in the anterior, posteromedial and posterolateral direction while standing on the other foot on a centralized stance platform.
|
Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
|
Change in Functional Movement Screen (FMS)
Time Frame: Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
The FMS is a screening tool used to identify limitations or asymmetries in movement patterns by executing seven motions.
Activities include a deep squat, lunges, hurdle steps, a push-up, straight-leg raises, shoulder mobility assessments, and rotary stability assessments.
|
Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Tegner Activity Scale
Time Frame: Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
|
Change in Marx Activity Scale
Time Frame: Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
|
Change in EQ-5D
Time Frame: Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
|
Change in SRS-22
Time Frame: Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
Preoperatively; 6wks, 3mos, 6mos, and 12mos Postoperatively
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Robert K Lark, MD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro00055257
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.